Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Baillie Gifford & Co Limited. | 8.16M (8.70%) | -60.90K Decreased by -0.75% | Mar 31, 25 |
2 | FMR Inc | 7.28M (7.76%) | -418.06K Decreased by -5.74% | Mar 31, 25 |
3 | Flossbach von Storch AG | 4.26M (4.54%) | -147.21K Decreased by -3.46% | Mar 31, 25 |
4 | PRIMECAP Management Company | 4.05M (4.31%) | -249.39K Decreased by -6.16% | Mar 31, 25 |
5 | Pfizer Inc | 3.66M (3.90%) | 0.00 Increased by 0.00% | Mar 31, 25 |
6 | Harding Loevner L.P. | 2.93M (3.12%) | -891.40K Decreased by -30.46% | Jun 30, 24 |
7 | Temasek Holdings Ltd. | 1.81M (1.93%) | 0.00 Increased by 0.00% | Mar 31, 25 |
8 | BlackRock Inc | 1.67M (1.78%) | -190.47K Decreased by -11.43% | Mar 31, 25 |
9 | Capital Research & Mgmt Co - Division 3 | 1.43M (1.52%) | 12.88K Increased by +0.90% | Mar 31, 25 |
10 | BNP Paribas Arbitrage, SA | 1.20M (1.27%) | 581.17K Increased by +48.61% | Mar 31, 25 |
11 | UBS Asset Mgmt Americas Inc | 995.25K (1.06%) | 137.12K Increased by +13.78% | Dec 31, 23 |
12 | Capital World Investors | 955.98K (1.02%) | 12.86K Increased by +1.35% | Jun 30, 24 |
13 | Viking Global Investors LP | 879.97K (0.94%) | -60.88K Decreased by -6.92% | Mar 31, 25 |
14 | Artisan Partners Limited Partnership | 734.62K (0.78%) | -1.30M Decreased by -176.37% | Sep 30, 23 |
15 | Aberdeen Group PLC | 721.93K (0.77%) | 336.26K Increased by +46.58% | Jun 30, 25 |
16 | Morgan Stanley - Brokerage Accounts | 713.61K (0.76%) | -29.78K Decreased by -4.17% | Mar 31, 25 |
17 | Bank of New York Mellon Corp | 698.37K (0.74%) | 694.69K Increased by +99.47% | Mar 31, 25 |
18 | Candriam Luxembourg S.C.A. | 670.96K (0.72%) | -175.98K Decreased by -26.23% | Mar 31, 25 |
19 | Gilder Gagnon Howe & CO LLC | 649.28K (0.69%) | 367.87K Increased by +56.66% | Mar 31, 25 |
20 | Amvescap Plc. | 645.14K (0.69%) | 558.39K Increased by +86.55% | Mar 31, 25 |
Rank | Holder | SharesFloat % | Change | Date reported |
---|---|---|---|---|
1 | Performer (AFRIS) | 30.26M (32.26%) | 30.26M Increased by +100.00% | Feb 29, 24 |
2 | Franklin All Country World ex US Equity | 20.00M (21.32%) | 20.00M Increased by +100.00% | Mar 31, 25 |
3 | FvS SICAV Multiple Opportunities F | 2.53M (2.69%) | -200.00K Decreased by -7.92% | Apr 30, 25 |
4 | AF High Growth (AFRIS) | 2.30M (2.45%) | 2.30M Increased by +100.00% | Feb 29, 24 |
5 | Vanguard Capital Opportunity Inv | 2.22M (2.36%) | 54.15K Increased by +2.44% | Jun 30, 25 |
6 | Harding Loevner International Eq Instl | 1.29M (1.38%) | -561.45K Decreased by -43.40% | Jun 30, 24 |
7 | FvS Multiple Opportunities II I | 1.12M (1.20%) | -139.23K Decreased by -12.41% | Apr 30, 25 |
8 | Global Balanced (AFRIS) | 1.05M (1.12%) | 1.05M Increased by +100.00% | Feb 29, 24 |
9 | T. Rowe Price Mid-Cap Growth | 1.02M (1.09%) | 375.10K Increased by +36.60% | Jun 30, 25 |
10 | T. Rowe Price US Mid-Cap Growth Equity | 1.02M (1.09%) | 1.02M Increased by +100.00% | Jun 30, 25 |
11 | PRIMECAP Odyssey Aggressive Growth | 975.66K (1.04%) | -68.70K Decreased by -7.04% | Jun 30, 25 |
12 | iShares Biotechnology ETF | 915.52K (0.98%) | -6.76K Decreased by -0.74% | Jul 30, 25 |
13 | NYLI Merger Arbitrage ETF | 893.33K (0.95%) | 0.00 Increased by 0.00% | Jul 29, 25 |
14 | American Funds New Perspective A | 798.14K (0.85%) | -1.38K Decreased by -0.17% | Jun 30, 24 |
15 | Capital Group New Perspective Comp | 798.14K (0.85%) | -1.38K Decreased by -0.17% | Jun 30, 24 |
16 | American Funds Europacific Growth A | 741.31K (0.79%) | 0.00 Increased by 0.00% | Mar 31, 25 |
17 | Capital Group EuroPacific Growth Comp | 741.31K (0.79%) | 0.00 Increased by 0.00% | Mar 31, 25 |
18 | Strategic Advisers Fidelity US TtlStk | 697.80K (0.74%) | -43.00K Decreased by -6.16% | Jun 30, 25 |
19 | Invesco Developing Markets A | 652.56K (0.70%) | 0.00 Increased by 0.00% | May 31, 25 |
20 | UBS (Lux) ES L/T Thms $Q | 626.66K (0.67%) | 0.00 Increased by 0.00% | Nov 30, 23 |